Amedica (AMDA) Misses Q2 EPS by 9c

Amedica (NASDAQ: AMDA) reported Q2 EPS of ($0.40), $0.09 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $4 million versus the consensus estimate of $4.2 million.

For earnings history and earnings-related data on Amedica (AMDA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c